Disease management
The company has developed a line of products targeting the mammography space to enable early and accurate breast cancer detection.
The system was cleared for use among individuals 12 years old and up with Type 1 or Type 2 diabetes on multiple-dose injection therapy.
Viome has adapted its technology to search for the presence of oral squamous cell carcinoma and oropharyngeal cancer in users’ saliva samples.
Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the software platforms and/or medical devices offered by the diabetes management companies.
General Atlantic, Centene and AXA Venture Partners led the Series D round.
MindMaze creates gamified digital neurotherapeutics for patients with neurological injuries and conditions such as stroke, traumatic brain injury, multiple sclerosis or Parkinson’s disease.
With this consent-driven initiative, Eden Health aims to give both employers and their workforce assurance that job sites can safely reopen and remain open.
The company collected $9 million in debt financing from SVB and $12 million in equity investments led by Savitr positions, according to its announcement.
Virta plans to use the funds to grow its platform to reach more patients.
The partnership with the Joslin Diabetes Center will add a panel of novel biomarkers to the indicators currently captured by KidneyIntelX.